ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,025.99
      -0.95%
      US Tech 100
      20,874.00
      -1.46%
      Dow Jones
      44,303.40
      -0.99%
      Brent Oil
      74.565
      0.00%
      Bitcoin
      97,201.93
      0.77%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Biosynex (ALBIO) Quote

      Biosynex

      Biosynex (ALBIO)

      EU
      1.18
      0.028
      (2.43%)
      Closed February 09 11:30AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      1.18
      Bid
      1.15
      Ask
      1.182
      Volume
      12,700
      1.152 Day's Range 1.18
      1.054 52 Week Range 7.95
      Market Cap
      12.698M
      Previous Close
      1.152
      Open
      1.152
      Last Trade
      43
      @
      1.18
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      21,695
      Shares Outstanding
      10,760,870
      Dividend Yield
      -
      PE Ratio
      -0.34
      Earnings Per Share (EPS)
      -3.43
      Revenue
      109.26M
      Net Profit
      -36.95M

      About Biosynex

      Sector
      Offices Of Medical Doctors
      Industry
      Offices Of Medical Doctors
      Website
      www.biosynex.com
      Headquarters
      Illkirch-graffenstaden, Bas-rhin, Fra
      Founded
      -
      Biosynex is listed in the Offices Of Medical Doctors sector of the Euronext with ticker ALBIO. The last closing price for Biosynex was 1.15 €. Over the last year, Biosynex shares have traded in a share price range of 1.054 € to 7.95 €.

      Biosynex currently has 10,760,870 shares outstanding. The market capitalization of Biosynex is 12.40 € million. Biosynex has a price to earnings ratio (PE ratio) of -0.34.

      Ask ADVFN Intelligence (AI)

      ALBIO Latest News

      More News

      REALISATION DE LA FUSION-ABSORPTION DE THERADIAG PAR BIOSYNEX

      Regulatory News: BIOSYNEX (Paris:ALBIO) et THERADIAG (Paris:ALTER) annoncent que les assemblées générales extraordinaires des actionnaires de THERADIAG SA (Euronext Paris : ALTER) et de BIOSYNEX...

      December 15 2023
      Business Wire

      Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.

      STRASBOURG, France, April 13, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, today announced...

      April 13 2023
      GlobeNewswire Inc.

      Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.

      STRASBOURG, France, March 15, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, today announced...

      March 15 2023
      GlobeNewswire Inc.

      Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement

      Complementary Technologies, Product Portfolios, and Market Opportunities Expected to Represent Significant Growth Drivers Consolidated Manufacturing, Sales, Marketing, Operations to Provide...

      January 31 2023
      GlobeNewswire Inc.

      BIOSYNEX : CROISSANCE ELEVEE DES RÉSULTATS SEMESTRIELS 2021

      Chiffre d’affaires multiplié par 5,1 EBE supérieur à 100 M€ Résultat net consolidé de 70,5 M€ (x11,3) DES FONDAMENTAUX SOLIDES POUR PREPARER L’APRES COVID-19 Fonds propres de 136,1 M€ Cash net...

      October 20 2021
      Business Wire

      BIOSYNEX : ACTIVITE TOUJOURS TRES SOUTENUE AU 3ÈME TRIMESTRE 2021

      CA T3 2021 à 84,8 M€, multiplié par 3 par rapport au CA T3 2020 Chiffre d’affaires 9 mois 2021 à plus de 300 M€ Regulatory News: BIOSYNEX (Paris:ALBIO) : RÉSULTATS SEMESTRIELS ATTENDUS EN...

      October 14 2021
      Business Wire

      BIOSYNEX : DÉCLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 30 SEPTEMBRE 2021

      Regulatory News: BIOSYNEX (Paris:ALBIO) : Publication du nombre d’actions composant le capital social et du nombre total de droits de vote (Article L.233-8 II du Code de commerce – Article...

      October 05 2021
      Business Wire

      BIOSYNEX LANCE LE 1ER TEST ANTIGÉNIQUE CONNECTABLE POUR LA DÉTECTION DU SARS-COV-2

      ACCÉLERATION DU GROUPE DANS LE DOMAINE DE L’E-SANTÉ Regulatory News: BIOSYNEX (Paris:ALBIO), leader dans les Tests de Diagnostic Rapide (TDR), annonce le lancement d’une version connectable du...

      September 14 2021
      Business Wire

      BIOSYNEX : DÉCLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 31 AOUT 2021

      Regulatory News: BIOSYNEX (Paris:ALBIO) : Publication du nombre d’actions composant le capital social et du nombre total de droits de vote (Article L.233-8 II du Code de commerce – Article...

      September 06 2021
      Business Wire

      BIOSYNEX : SIGNATURE D’UN TERM-SHEET POUR LE FINANCEMENT SYNDIQUÉ D’UN MONTANT TOTAL MAXIMUM DE 109 M€

      Regulatory News: BIOSYNEX (Paris: ALBIO), conseillé par Natixis Partners Debt Advisory, annonce la signature le 6 août 2021 d’un mandat d’arrangement et d’un term-sheet pour la mise en place...

      August 09 2021
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.088-6.940063091481.2681.2681.054404341.16110713DE
      4-1.01-46.11872146122.192.311.054273791.36951647DE
      12-1.53-56.45756457562.712.921.054216951.67876116DE
      26-2.5-67.93478260873.686.921.054194003.46282477DE
      52-6.77-85.15723270447.957.951.054139733.80206053DE
      156-15.82-93.05882352941721.841.0541786312.44184183DE
      260-2.02-63.1253.230.381.0547075716.00630485DE

      ALBIO - Frequently Asked Questions (FAQ)

      What is the current Biosynex share price?
      The current share price of Biosynex is 1.18 €
      How many Biosynex shares are in issue?
      Biosynex has 10,760,870 shares in issue
      What is the market cap of Biosynex?
      The market capitalisation of Biosynex is EUR 12.4M
      What is the 1 year trading range for Biosynex share price?
      Biosynex has traded in the range of 1.054 € to 7.95 € during the past year
      What is the PE ratio of Biosynex?
      The price to earnings ratio of Biosynex is -0.34
      What is the cash to sales ratio of Biosynex?
      The cash to sales ratio of Biosynex is 0.12
      What is the reporting currency for Biosynex?
      Biosynex reports financial results in EUR
      What is the latest annual turnover for Biosynex?
      The latest annual turnover of Biosynex is EUR 109.26M
      What is the latest annual profit for Biosynex?
      The latest annual profit of Biosynex is EUR -36.95M
      What is the registered address of Biosynex?
      The registered address for Biosynex is 22 BOULEVARD SEBASTIEN BRANT, ILLKIRCH-GRAFFENSTADEN, BAS-RHIN, 67400
      What is the Biosynex website address?
      The website address for Biosynex is www.biosynex.com
      Which industry sector does Biosynex operate in?
      Biosynex operates in the OFFICES OF MEDICAL DOCTORS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ALCABCabasse SA
      0.77 €
      (67.39%)
      		93.29k
      ALEXPOne Experience
      0.496 €
      (64.24%)
      		2.54k
      VTRVitura
      5.80 €
      (62.92%)
      		2.37k
      DMSBSDiagnostic Medical Systems
      0.007 €
      (40.00%)
      		15.1k
      ALVERVergnet
      0.0009 €
      (28.57%)
      		23.09M
      ALCYBCybergun
      0.0001 €
      (-50.00%)
      		41.24k
      BAIOdyssey Acquisition SA
      0.1285 €
      (-49.80%)
      		834.05k
      ALALOAcheterLouerFR
      0.0148 €
      (-34.80%)
      		675.2k
      MLWEYWeya
      0.018 €
      (-33.33%)
      		52.31k
      MLCOTCoretech 5
      0.0335 €
      (-33.00%)
      		61k
      ATOAtos SE
      0.0021 €
      (0.00%)
      		1.12B
      ALVERVergnet
      0.0009 €
      (28.57%)
      		23.09M
      ALCYBCybergun
      0.0001 €
      (-50.00%)
      		18.59M
      ALHGLouis Hachette Group
      1.331 €
      (-2.90%)
      		11.49M
      BCPBanco Comercial Portugues SA
      0.5008 €
      (-1.14%)
      		10.67M

      Discussion

      View Full Feed
      LVerstee LVerstee 4 minutes ago
      I’ll wait. You either missed it or chose not to acknowledge it. Your insults don’t affect me, and I won’t take any satisfaction when you eventually understand what I mean. Not with you.
      ITUP
      DMC8 DMC8 5 minutes ago
      https://www.sciencedirect.com/science/article/pii/S104366182500060X
      AMRN
      jeunke22 jeunke22 6 minutes ago
      One would imagine these guys have business plans in place and are aware of the critical success factors. I guess Deep Seek was a wake up call to keep an eye on capex, costs , power and sustainability.

      https://www.cnbc.com/2025/02/08/tech-megacaps-to-spend-more-than-300-billion-in-2025
      LWLG
      theswordman theswordman 7 minutes ago
      What exactly was his contribution on those papers that had him listed as an author?

      What exactly was his contribution on EVERY SEC filing that had him listed as CEO?

      Absolutely nothing--say it again (What is IT good for?) Absolutely nothing

      Leronlimab des
      CYDY
      janice shell janice shell 10 minutes ago
      Impressive!

      https://x.com/gunsnrosesgirl3/status/1888500878446887109
      janice shell janice shell 15 minutes ago
      Why do these kinds of people never seem to understand they look like incels playing dress-up?

      They get home and Mom asks, "What?? You BURNED that outfit I spend two days making for you??"
      janice shell janice shell 26 minutes ago
      Oh yes, Two hundred years of brilliant Russian novels. Similar to our own tradition in its quality and duration, really, except that none of our authors were ever sent off to the Gulag. The military, yes, but not political prison camps. However, it's a bit late to enter on a discussion of comparativ
      janice shell janice shell 33 minutes ago
      Oh my! So the Man Camp guy also runs a megachurch in Ohio? Do we think he knows Paula? Perhaps he does Manly things with her?

      But as far as Crusher is concerned, I just think it's SO exciting to have our very first BOLSHIE on the board!! Not a mere Pinko, a BOLSHEVIK!!
      fliper fliper 41 minutes ago
      Fridays filing fwiw:
      https://www.otcmarkets.com/filing/html?id=18167517&guid=mf0-kqyAqwruQOh
      HADV
      janice shell janice shell 43 minutes ago
      Nice, dear. And today a federal judge gave Musk and his DOGEbags the smackdown they've been asking for.

      So one of those DOGEbags spent a good deal of time posting on the social media, "I was a white supremacist before it was cool!" and other repellent stuff. Musk chuckled and said boy
      igotthemojo igotthemojo 45 minutes ago
      "As of December 31, 2023, there was $2,617,211 in loan interest"

      nope...there was $1.6 mil in outstanding LOANS (not interest)...

      "As of December 31, 2024, there was a preliminary and unaudited $304,545 in loan interest"

      correct...$304,545 in INTEREST acc
      KBLB
      lovethatgreen lovethatgreen 45 minutes ago
      Thia account is suspended until Nov 2027
      RITE
      cptbac cptbac 47 minutes ago
      Exactly.
      NWBO
      janice shell janice shell 50 minutes ago
      By the way, I just watched that video. What on earth presumably makes you believe I think this country is okay, and going in the right direction?

      I should have imagined that you'd understood from my many posts that I think we're headed to hell in a handbasket. Unlike you, I do not fe
      StocktonCA StocktonCA 53 minutes ago
      this bill is on the current Congress' calender to be discussed sometime before the end of Feb

      Shown Here:
      Introduced in Senate (03/28/2023)

      Setting Consumer Standards for Lithium-Ion Batteries Act

      This bill requires the Consumer Product Safety Comm
      TORVF
      Chachang1 Chachang1 56 minutes ago
      It's nearly March. This stock has a history of running hard in March. First the float gets soaked up cheap which we have been seeing happening. Next, the Company will put out press and other media. Watch for this as they have been silent. Then boom, a run. As Florida stated he ran this from down her
      RLTR
      StocktonCA StocktonCA 57 minutes ago
      Shown Here:
      Introduced in Senate (03/28/2023)

      Setting Consumer Standards for Lithium-Ion Batteries Act

      This bill requires the Consumer Product Safety Commission to issue a consumer product safety standard for rechargeable lithium-ion batteries used in micromobili
      KULR
      TightCoil TightCoil 1 hour ago
      Remember Buffett's Famous Fannie Fumble -
      How he always wanted to own "The Lion's Share,"
      of FNMA...Aah, What Might Have Been - What
      Could Have Been....now gone...or is it?
      FNMA
      Chachang1 Chachang1 1 hour ago
      Some guys in one of my groups were talking about a major partnership with Ecite that will put this worldwide. Supposedly a bigger player than Lucid.
      VAPR
      janice shell janice shell 1 hour ago
      Looks to me like a lot of neo fascist, antisemitic claptrap, but hey, I guess I'm just too old to appreciate the return of Mussolini in the form of Orban.

      Nonetheless, I'm the one with the Ph.D., not you.
      timmins4 timmins4 1 hour ago
      You are correct, Honore has no use for Trump.
      AGSS

      Your Recent History

      EU
      ALBIO
      Biosynex
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads